04:21 PM EDT, 03/25/2025 (MT Newswires) -- Rakovina Therapeutics ( RKVTF ) after trade Tuesday said two of its abstracts have been accepted for presentation at the upcoming 2025 American Association for Cancer Research (AACR) Annual Meeting, taking place April 25-30 in Chicago.

According to a statement the AACR Annual Meeting is widely considered the most prestigious global forum for cancer research. It said Rakovina's acceptance to present, highlights "growing recognition for its pioneering work at the intersection of AI technology and precision cancer therapy".

Rakovina shares closed down $0.015 to $0.115 on the TSX Venture Exchange.